Back to Atlas
CTransientStandard research/education caution
CMP-0266
Investigational/topical research
Afimoxifene / 4-hydroxytamoxifen
Endocrine / SERM
Topical/systemic antiestrogen research positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- SERM metabolite
- Primary mechanism
- Potent active tamoxifen metabolite; ER modulation
- Primary market use
- Oncology / endocrine research
Pharmacology
- Molecular weight (Da)
- 387.5
- Oral bioavailability
- Oral data not established as standalone
- Half-life
- ~14 d reported
- Route tags
- Topical; oral/other route-dependent
- Evidence level
- Clinical/research
- Clinical status
- Investigational/topical research
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Important active metabolite; standalone use niche/investigational